BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science based health an… Read more
BioHarvest Sciences Inc. Common Stock (BHST) - Net Assets
Latest net assets as of September 2025: $7.74 Million USD
Based on the latest financial reports, BioHarvest Sciences Inc. Common Stock (BHST) has net assets worth $7.74 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($35.19 Million) and total liabilities ($27.45 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $7.74 Million |
| % of Total Assets | 21.98% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
BioHarvest Sciences Inc. Common Stock - Net Assets Trend (2020–2024)
This chart illustrates how BioHarvest Sciences Inc. Common Stock's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for BioHarvest Sciences Inc. Common Stock (2020–2024)
The table below shows the annual net assets of BioHarvest Sciences Inc. Common Stock from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $1.33 Million | +108.95% |
| 2023-12-31 | $-14.85 Million | -150.51% |
| 2022-12-31 | $-5.93 Million | -307.67% |
| 2021-12-31 | $2.85 Million | +224.40% |
| 2020-12-31 | $-2.29 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to BioHarvest Sciences Inc. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4654000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $97.75 Million | 7349.47% |
| Total Equity | $1.33 Million | 100.00% |
BioHarvest Sciences Inc. Common Stock Competitors by Market Cap
The table below lists competitors of BioHarvest Sciences Inc. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Financiere Moncey S.A.
PA:FMONC
|
$95.66 Million |
|
Arsan Tekstil Ticaret ve Sanayi AS
IS:ARSAN
|
$95.66 Million |
|
Xplora Technologies As
OL:XPLRA
|
$95.72 Million |
|
Taylor Calvin B Bksh
OTCQX:TYCB
|
$95.73 Million |
|
Happy Belly Food Group Inc.
OTCQB:HBFGF
|
$95.65 Million |
|
Dohome Public Company Limited
BK:DOHOME
|
$95.62 Million |
|
CBRAIN AS DK -25
F:C6F
|
$95.61 Million |
|
FABRYKA FARB I LAK. ZY 1
F:695
|
$95.58 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BioHarvest Sciences Inc. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -14,853,000 to 1,330,000, a change of 16,183,000.
- Net loss of 12,913,000 reduced equity.
- New share issuances of 4,330,000 increased equity.
- Other factors increased equity by 24,766,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-12.91 Million | -970.9% |
| Share Issuances | $4.33 Million | +325.56% |
| Other Changes | $24.77 Million | +1862.11% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares BioHarvest Sciences Inc. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 74.78x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $-0.20 | $5.74 | x |
| 2021-12-31 | $0.22 | $5.74 | x |
| 2022-12-31 | $-0.45 | $5.74 | x |
| 2023-12-31 | $-1.09 | $5.74 | x |
| 2024-12-31 | $0.08 | $5.74 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BioHarvest Sciences Inc. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -970.90%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -51.27%
- • Asset Turnover: 1.01x
- • Equity Multiplier: 18.80x
- Recent ROE (-970.90%) is below the historical average (-263.02%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 0.00% | -1662.63% | 0.07x | 0.00x | $-6.35 Million |
| 2021 | -344.20% | -467.51% | 0.21x | 3.58x | $-10.11 Million |
| 2022 | 0.00% | -204.37% | 0.59x | 0.00x | $-10.64 Million |
| 2023 | 0.00% | -99.15% | 0.84x | 0.00x | $-11.08 Million |
| 2024 | -970.90% | -51.27% | 1.01x | 18.80x | $-13.05 Million |
Industry Comparison
This section compares BioHarvest Sciences Inc. Common Stock's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $5,681,533,529
- Average return on equity (ROE) among peers: 0.04%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BioHarvest Sciences Inc. Common Stock (BHST) | $7.74 Million | 0.00% | 3.55x | $95.65 Million |
| Above Food Ingredients Inc. Common Stock (ABVE) | $30.90K | -3.31% | 7.66x | $18.76 Million |
| The a2 Milk Company Limited (ACOPF) | $7.27 Million | -30.19% | 0.14x | $3.91 Billion |
| Ayujoy Herbals Ltd (AJOY) | $22.20 Million | 29.29% | 0.00x | $95.71 |
| Alfa S.A.B. de C.V (ALFFF) | $53.35 Billion | 7.36% | 3.80x | $2.16 Billion |
| Amincor Inc (AMNCB) | $34.44 Million | -63.76% | 0.81x | $2.24K |
| Armanino Foods New (AMNF) | $21.40 Million | 30.30% | 0.33x | $72.33K |
| Amira Nature Foods Ltd (ANFIF) | $303.22 Million | 8.27% | 0.89x | $128.79 |
| AAK AB (publ.) (ARHUF) | $2.44 Billion | 12.85% | 2.63x | $5.07 Billion |
| Artisan Consumer Goods Inc (ARRT) | $-326.75K | 0.00% | 0.00x | $279.39K |
| ARYZTA AG (ARZTF) | $632.10 Million | 9.58% | 2.04x | $53.13 Million |